KOH 5% untuk Terapi Alternatif Kondiloma Akuminata di Pusat Pelayanan Kesehatan Primer
DOI:
https://doi.org/10.55175/cdk.v45i6.779Kata Kunci:
KOH 5%, kondiloma akuminata, terapiAbstrak
Kondiloma akuminata atau kutil kelamin merupakan infeksi Human Papilloma Virus (HPV) yang ditandai dengan lesi vegetasi bertangkai atau papil yang berjonjot. Salah satu terapi yang sedang dikembangkan, khususnya di negara berkembang seperti Indonesia, adalah KOH 5%. KOH 5% merupakan larutan basa kuat bersifat keratolitik, yang memiliki beberapa keuntungan dibandingkan terapi lain. KOH 5% diharapkan dapat digunakan sebagai terapi alternatif kondiloma akuminata di setiap pusat pelayanan kesehatan primer di Indonesia.
Condylomata akuminata or genital warts is an infection of Human Papilloma Virus (HPV) which is characterized by vegetation of stemmed or papilloed vegetation. One of the therapies which is being developed, especially in developing countries such as Indonesia, is KOH 5%. KOH 5% is a strong keratolytic base solution, which has several advantages over other therapies. KOH 5% is expected to be used as an alternative therapy of condyloma akuminata in every primary health care center in Indonesia.
Unduhan
Referensi
Cunningham, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY. Williams Obstetrics. 23rd Ed. McGraw Hill Medical; 2010.
Holmes KK, Sparling PF, Stamm WE, Piot P, Wasserheit J, Corey L, et al. Sexually transmitted diseases. 4th Ed. McGraw Hill Medical; 2008.
World Health Organization. Human papillomavirus (HPV) [Internet]. World Health Organization [cited 2010 Sept]. Available from: http://www.who.int.
Center for Disease Control and Prevention. STIs among Young Americans [Internet]. [cited 2013 April]. Available from: http://www.cdc.gov.
Izwardy ME, Saputera MD. 5% potassium hydroxide: A promising new treatment for anogenital warts. Indonesia: East Asian Medical Student’s Conference; 2015.
Isik S, Koca R, Sarici G, Altinyazar HC. A comparison of a 5% potassium hydroxide solution with a 5-fluorouracil and salicylic acid combination in the treatment ofpatients with anogenital warts: A randomized, open-label clinical trial. Internat J Dermatol. 2014;53(9):1145-50.
De Abreu Camargo, Belda W, Junior, Fagundes LJ, Romiti R. A prospective, open, comparative study of 5% potassium hydroxide solution versus cryotherapy in the treatment of genital warts in men. Anais Brasileiros de Dermatol. 2014;89(2):236-41.
Al-Hamdi K, Al-Rahmani MAA. Evaluation of topical potassium hydroxide solution for treatment of plane warts. Indian J Dermatol. 2012;57(1):38-41.
Rimkevicius A, Puriene A, Gaigalas M. Condyloma acuminatum: Some aspects. Acta Medica Lituanica. 2011;18(2):43-6.
Kui LL, Xiu HZ, Ning LY. Condyloma acuminatum and human papilloma virus infection in the oral mucosa of children. J Pediatr Dentistr. 2003;25(2):149-53.
Chang GJ, Welton ML. Human papillomavirus, condylomata acuminate, and anal neoplasia. Clinics in Colon and Rectal Surgery 2004;17(4):221-30.
Bain CM, Burton K, McGavigan J. Gynecology illustrated. 6th Ed. Churchill Livingstone: Elsevier; 2011.
Kementerian Kesehatan RI Direktorat Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan. Pedoman nasional penanganan infeksi menular seksual 2011. Indonesia: Kementerian Kesehatan RI; 2011.
Kodner CM, Nasraty S. Management of genital warts [Internet]. Am Fam Phys [cited 2014 Dec]. Available from: http://www.aafp.org.
Unduhan
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2018 https://creativecommons.org/licenses/by-nc/4.0/
Artikel ini berlisensi Creative Commons Attribution-NonCommercial 4.0 International License.
